4582 シンバイオ製薬 企業サイト Yahooファイナンス 日経新聞 株探
基本データ
【業種】医薬品【市場】グロース（内国株式）
【決算期】12月
【会社設立】2005.3
【上場】2011.10
【直近決算日】2024-05-07
【決算予定日】
【時価総額】71億3000万円
【予想PER】 倍
【PBR】1.02 倍
【自己資本比率】86.9 %
業績予想（通期のみ）
| 年度 | タイプ | 日付 | 売上高 | 営業利益 | 経常利益 | 純利益 |
|---|---|---|---|---|---|---|
| 2022-12 | 新規 | 2022-02-10 | 10992 | 1770 | 1750 | 1480 |
| 修正 | 2022-08-04 | 10003(↓) | 1770(→) | 1750(→) | 1480(→) | |
| 修正 | 2022-11-08 | 10003(→) | 2000(↑) | 2300(↑) | 1650(↑) | |
| 2023-12 | 新規 | 2023-02-09 | 7000 | -331 | -351 | -370 |
| 修正 | 2023-08-03 | 6477(↓) | -331(→) | -219(↑) | -370(→) | |
| 修正 | 2023-11-14 | 5603(↓) | -680(↓) | -549(↓) | -1291(↓) | |
| 2024-12 | 新規 | 2024-02-08 | 3641 | -2837 | -2867 | -2870 |
| 修正 | 2024-05-07 | 2623(↓) | -3702(↓) | -3524(↓) | -3628(↓) |
| 決算期 | 四半期 | 売上高 | 営業利益 | 経常利益 | 純利益 | 営業利益率 | 経常利益率 | 売上高/前年比 | 営業利益/前年比 | 経常利益/前年比 | 純利益/前年比 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 予想 | 2623 | -3702 | -3524 | -3628 | ― | ― | -53.1% | ― | ― | ― | |
| 2024-12 | 1 | 597 | -806 | -727 | -777 | -135.01% | -121.78% | -61.3% | ― | ― | ― |
| 2023-12 | 4 | 5589 | -811 | -736 | -1962 | -14.51% | -13.17% | -44.1% | ― | ― | ― |
| 3 | 4421 | -283 | -156 | -788 | -6.4% | -3.53% | -39.9% | ― | ― | ― | |
| 2 | 3178 | -49 | 66 | -79 | -1.54% | 2.08% | -34.8% | ― | -95.4% | ― | |
| 1 | 1544 | 51 | 48 | 4 | 3.3% | 3.11% | -33.3% | -89.9% | -89.9% | -97.3% | |
| 2022-12 | 4 | 10008 | 1963 | 1999 | 1179 | 19.61% | 19.97% | 0% | ― | ― | ― |
| 3 | 7355 | 1588 | 1843 | 1555 | 21.59% | 25.06% | ― | ― | ― | ― | |
| 2 | 4873 | 1372 | 1447 | 1108 | 28.16% | 29.69% | ― | ― | ― | ― | |
| 1 | 2315 | 509 | 478 | 163 | 21.99% | 20.65% | ― | ― | ― | ― | |
| 2021-12 | 4 | 8256 | 1016 | 1001 | 2032 | 12.31% | 12.12% | 176.4% | ― | ― | ― |
| 3 | 5553 | 424 | 414 | 324 | 7.64% | 7.46% | 138.1% | ― | ― | ― | |
| 2 | 3146 | -194 | -203 | -205 | -6.17% | -6.45% | 131.3% | ― | ― | ― | |
| 1 | 1420 | -210 | -208 | -209 | -14.79% | -14.65% | 157.6% | ― | ― | ― | |
| 2020-12 | 4 | 2987 | -4506 | -4615 | -4090 | -150.85% | -154.5% | 5.3% | ― | ― | ― |
| 3 | 2332 | -3142 | -3220 | -2694 | -134.73% | -138.08% | 16.2% | ― | ― | ― | |
| 2 | 1360 | -1839 | -1883 | -1884 | -135.22% | -138.46% | -32.1% | ― | ― | ― | |
| 1 | 551 | -961 | -991 | -992 | -174.41% | -179.85% | -65.8% | ― | ― | ― | |
| 2019-12 | 4 | 2837 | -4301 | -4376 | -4376 | -151.6% | -154.25% | -26% | ― | ― | ― |
| 3 | 2008 | -3536 | -3641 | -3640 | -176.1% | -181.32% | -33.8% | ― | ― | ― | |
| 2 | 2004 | -2015 | -2069 | -2069 | -100.55% | -103.24% | 4% | ― | ― | ― | |
| 1 | 1611 | -595 | -616 | -616 | -36.93% | -38.24% | 81.4% | ― | ― | ― | |
| 2018-12 | 4 | 3835 | -2656 | -2748 | -2752 | -69.26% | -71.66% | 11.4% | ― | ― | ― |
| 3 | 3032 | -1907 | -1937 | -1940 | -62.9% | -63.89% | 25.5% | ― | ― | ― | |
| 2 | 1928 | -1324 | -1377 | -1388 | -68.67% | -71.42% | 7.95% | ― | ― | ― | |
| 1 | 888 | -714 | -748 | -759 | -80.41% | -84.23% | 2.19% | ― | ― | ― | |
| 2017-12 | 4 | 3444 | -3947 | -3976 | -3977 | -114.61% | -115.45% | 45.44% | ― | ― | ― |